Abstract:Objective: The objective of this study was to evaluate the efficacy of hysteroscopic electroresection in the treatment of atypical endometrial hyperplasia and to determine the prognostic factors. Methods: 226 patients with endometrial dysplasia treated in hospital from January 2021 to August 2022 were selected and divided into control group (113 cases) and study group (113 cases) according to different treatment methods selected by the patients themselves. The control group received curettage plus conventional progesterone treatment, while the study group received hysteroscopic electroresection plus conventional progesterone treatment. After 6 months of treatment, the clinical efficacy (complete response, partial response and progress) of the two groups were evaluated, complications and adverse drug reactions of the two groups were analyzed, and estrogen levels before and after treatment were compared between the two groups. After 1 year follow-up, patients were divided into relapse group and non-recurrence group according to whether they had relapse or not. Clinical data of the two groups were compared to analyze the related factors affecting the prognosis of patients. Results: (1) Chi-square test results showed that the total effective rate of the study group was higher (96.46% VS 77.88%) than that of the control group (P < .05). The complication rate and recurrence rate of the study group were lower than those of the control group (1.77% VS 7.96%, 4.42% VS 21.24%) (P < .05). (2) t test results of independent samples showed that after 6 months of treatment, the levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in the study group were lower than those in the control group (P < .05); (3) The t test results of independent samples indicated that the age and body mass index of the relapsed group were higher than those of the non-relapsed group (P < .05); Chi-square test results showed that the proportion of diabetes was higher than that of the group without recurrence, and the proportion of hysteroscopic electroresection was lower than that of the group without recurrence (P < .05). (4) Logistic regression model was established, and the results showed that age (OR=1.159), body mass index (OR=1.529) and diabetes (OR=3.861) were the risk factors for prognosis of patients with endometrial dysplasia (P < .05), and hysteroscopic electroresection was the protective factor (OR < 1, P < .05). Conclusion: Hysteroscopic electroresection shows significant potential in the treatment of atypical hyperplasia of endometrial, and can improve clinical efficacy and reduce complications by effectively regulating estrogen secretion. In addition, studies have shown that the prognosis of endometrial dysplasia may be related to the age of patients, body mass index and diabetes mellitus. Therefore, for patients with the above risk factors, early consideration of hysteroscopic electrotomy therapy is recommended to reduce recurrence rates and provide important informational support for treatment protocols and clinical guidelines.

Evaluation on Surgical Curative Effect of Atypical Hyperplasia of Endometrium

Outcome of Conservative Treatment and Subsequent Assisted Reproductive Technology for Patients with Early-Stage Endometrial Adenocarcinoma and Poor Fertility Potential

Efficacy of Transcervical Resection of Endometrium for Adenomyosis

Effect of gonadotropin-releasing hormone agonist therapy after laparoscopic conservative surgery with moderate to severe endometriosis

[Analysis of the Efficiency of Transcervical Resection of Endometrium for Treating Dysfunctional Uterine Bleeding and Factors Reducing the Efficiency of the Operation].

Analysis of the Therapeutic Efficacy of Hysteroscopic Electric Resection in the Treatment of Atypical Endometrial Hyperplasia and Factors Influencing Prognosis

[Effects of Pathological Assessment of Endometrial Tissue in Fertility-Sparing Treatment with Progestin for Endometrial Carcinoma of Stage I a and Complex Atypical Hyperplasia].

[Transcervical Resection of Myoma in Treatment of Hysteromyoma, Experience in 962 X\cases].

Relationship Between the Expression of PTEN, ER and PR and the Prognosis of TCRE in Endometrial Hyperplasia

Transcervical resection of endometrium for inhibition of proliferative response of endometrium in women with breast cancer on adjuvant tamoxifen

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy

Management of endometrioid carcinomapatients with preoperative diagnosis of endometrial hyperplasia

Treatment Efficiency of Comprehensive Hysteroscopic Evaluation and Lesion Resection Combined with Progestin Therapy in Young Women with Endometrial Atypical Hyperplasia and Endometrial Cancer.

Clinical Features and Outcome of 15 Patients with Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Received Primary Fertility-Sparing Therapy Followed by Hysterectomy

[Evaluation of Diagnosis of Endometrial Hyperplasia by Curettage].

The Occurrence and Outcome of 39 Pregnancies after 1621 Cases of Transcervical Resection of Endometrium

Outcome of Pregnancy after Transcervical Resection of Endometrium

The factors that affect the efficacy of hysteroscope in the treatment of abnormal menstruation caused by intrauterine adhesions

The Variety of Expressions of Microvessel Density, Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor (KDR) in Endometrium Before and after Transcervical Resection of Endometrium

Accuracy of Tumor Grade by Preoperative Curettage and Associated Clinicopathologic Factors in Clinical Stage I Endometriod Adenocarcinoma

Outcomes of conservative treatment of endometrial atypical hyperplasia and strategy of assisted reproduction for these patients